72 related articles for article (PubMed ID: 7052613)
1. [Effect of transfer factor on surgical treatment of primary lung cancer].
Yamaguchi Y
Rinsho Kyobu Geka; 1981; 1(3):397-405. PubMed ID: 7052613
[No Abstract] [Full Text] [Related]
2. [Transfer factor (TFX) dosage and the clinical course of primary lung carcinoma].
Słowik-Gabryelska A; Krzyśko R
Pneumonol Pol; 1980 Mar; 48(3):187-93. PubMed ID: 7367309
[No Abstract] [Full Text] [Related]
3. [Transfer factor immunotherapy of oncological patients].
Berezhnaia NM; Slinchak SM; Petrovskaia IA; Bezverkhiĭ VD; Kotova SA
Vopr Onkol; 1981; 27(2):89-91. PubMed ID: 7210602
[No Abstract] [Full Text] [Related]
4. [Transfer factor immunotherapy as an adjunct to surgery in lung cancer].
Fujisawa T
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Jan; 23(1):68-73. PubMed ID: 3892117
[No Abstract] [Full Text] [Related]
5. [The therapeutic effects of auto-transfer-factor and iRNA in lung cancer (author's transl)].
Deng WW
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Dec; 3(4):199-200. PubMed ID: 6170493
[No Abstract] [Full Text] [Related]
6. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
Kakimi K; Nakajima J; Wada H
Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127
[TBL] [Abstract][Full Text] [Related]
7. Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma.
Fujisawa T; Yamaguchi Y
Cancer; 1996 Nov; 78(9):1892-8. PubMed ID: 8909308
[TBL] [Abstract][Full Text] [Related]
8. Effective cell transfer immunotherapy for lung cancer and its metastasis.
Maeda Y; Yamaguchi T; Hijikata Y; Hayata K; Tagawa Y; Yamamoto T; Oka Y; Dohi H
Acta Oncol; 2008; 47(2):320-2. PubMed ID: 17926145
[No Abstract] [Full Text] [Related]
9. [Immunological aspects of primary cancer of the lung].
Blasi A
Arch Monaldi; 1985; 40(5-6):187-202. PubMed ID: 3843169
[No Abstract] [Full Text] [Related]
10. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H
Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
[TBL] [Abstract][Full Text] [Related]
11. Orally administered specific transfer factor for the treatment of herpes infections.
Viza D; Vich JM; Phillips J; Rosenfeld F
Lymphokine Res; 1985; 4(1):27-30. PubMed ID: 4039018
[No Abstract] [Full Text] [Related]
12. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
[TBL] [Abstract][Full Text] [Related]
13. Cytokine immunotherapy of non-small cell lung cancer.
Dubinett SM; Kradin RL
Reg Immunol; 1993; 5(3-4):232-43. PubMed ID: 8240940
[No Abstract] [Full Text] [Related]
14. Immunogenic targets in non-small cell lung cancer: more is more.
Gnjatic S
Clin Cancer Res; 2005 Aug; 11(15):5331-2. PubMed ID: 16061843
[No Abstract] [Full Text] [Related]
15. Small-cell lung cancer.
Simon G; Ginsberg RJ; Ruckdeschel JC
Chest Surg Clin N Am; 2001 Feb; 11(1):165-88, ix. PubMed ID: 11253596
[TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy of leprosy (2nd report). Study on the therapy by means of injection of transfer factor (author's transl)].
Okada S; Izumi S; Sugiyama K
Nihon Rai Gakkai Zasshi; 1980; 49(4):190-6. PubMed ID: 7298544
[No Abstract] [Full Text] [Related]
18. Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancer.
Wilderman MJ; Kim S; Gillespie CT; Sun J; Kapoor V; Vachani A; Sterman DH; Kaiser LR; Albelda SM
Mol Ther; 2006 May; 13(5):910-7. PubMed ID: 16488193
[TBL] [Abstract][Full Text] [Related]
19. Current immunotherapeutic strategies in lung cancer.
Rüttinger D; Hatz RA; Jauch KW; Fox BA
Surg Oncol Clin N Am; 2007 Oct; 16(4):901-18, x. PubMed ID: 18022551
[TBL] [Abstract][Full Text] [Related]
20. Non-small-cell lung cancer vaccine therapy: a concise review.
O'Mahony D; Kummar S; Gutierrez ME
J Clin Oncol; 2005 Dec; 23(35):9022-8. PubMed ID: 16219932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
